Candel Therapeutics Inc
Candel Therapeutics Inc (CADL) Option Chain
As of September 28, 2026, Candel Therapeutics Inc is trading at $10.86, a -2.95% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 188.1%. IV Rank is 66%.
Read more
Tracking the CADL option chain helps you see every strike and expiry on Candel Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Candel Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CADL options activity at a glance. Use our scanner to monitor the CADL option chain in real time and filter for the CADL options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CADL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CADL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CADL stock options are being actively traded and where they are not.
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc.
and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Candel Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CADL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CADL stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile60.71% Neutral
- Market cap (M$)856
- 52 weeks high-20.07%
- 52 weeks low157.24%
- Analyst recommendationStrong Buy
1.00 - Target price$21.75
93.37% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-1.41
- EPS growth next 5 years—
As of September 28, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 37.32 | 261 | 0 | 0.09 | 1.86 | 0.10 | 3.80 | 9.00 | -19.57 | — | 1.90 | 0.00 | 1.90 | 0 | 157 | 62.68 |
| 47.25 | 99 | 0 | 1.64 | 0.86 | 0.10 | 4.90 | 10.00 | -10.63 | 0.20 | 0.50 | 0.00 | 0.35 | 0 | 234 | 52.75 |
| 56.40 | 117 | 0 | 1.08 | 0.00 | 0.15 | 2.00 | 11.00 | -1.70 | — | 4.90 | 0.14 | 4.76 | 0 | 154 | 43.60 |
| 64.47 | 686 | 2 | 0.58 | 0.00 | 0.15 | 1.00 | 12.00 | +7.24 | — | 4.90 | 1.14 | 3.76 | 0 | 62 | 35.53 |
| 71.37 | 14 | 0 | 0.95 | 0.00 | — | 0.95 | 13.00 | +16.18 | 0.10 | 4.90 | 2.14 | 0.36 | 0 | 2 | 28.63 |
As of September 28, 2026
Scan the full option chain in one place
Browse the full CADL option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→